Search This Blog

Thursday, July 29, 2021

Glaxo: FDA APPROVAL FOR NUCALA (MEPOLIZUMAB) FOR CHRONIC RHINOSINUSITIS

 https://www.marketscreener.com/news/latest/GSK-ANNOUNCES-FDA-APPROVAL-FOR-NUCALA-MEPOLIZUMAB-FOR-USE-IN-ADULTS-WITH-CHRONIC-RHINOSINUSITIS-WI--36009004/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)